Taken together with the known crucial role of NF-κB in lung cancer cells,33 our results indicate that the small fragment of P65 180-200 may be a promising clue to development of drugs targeting lung cancer with overexpression of PRAS40. This evidence concerns the gene AKT1S1 and lung carcinoma.